Loading…
Outset Medical, Inc.
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in OM.
▼ -99.6% over 5Y.
today you would have $4.11▼ -99.6%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 6 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Year-end price | $3.71 | $16.65 | $81.15 | $387.30 | $691.35 | $852.60 | |
| P/S | 6.5x | 0.6x | 0.5x | 2.1x | 10.9x | 21.3x | 48.7x |
| P/B | 3.7x | 0.5x | 2.2x | 2.2x | 5.1x | 5.8x | 7.4x |
| EPS | -$5.37 |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| ELTXElicio Therapeutics, Inc. | $2.84 | — | 7.8x | — | -774.56% | $74.64M |
| LONALeonaBio, Inc. | $7.94 | — | 2.2x | — | -431.39% | $74.81M |
| ANVSAnnovis Bio, Inc. | $1.72 | — | — | — | -703.68% | $73.28M |
| PMVPPMV Pharmaceuticals, Inc. | $1.37 |
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Company description provided by Yahoo Finance.
| -$36.96 |
| -$52.28 |
| -$50.70 |
| -$43.35 |
| -$72.75 |
| Profit margin | -130.56% | -68.34% | -112.57% | -132.54% | -141.24% | -128.59% | -243.30% |
| ROE | -65.28% | -64.32% | -477.18% | -140.62% | -66.24% | -35.27% | -36.97% |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| — |
| 1.0x |
| — |
| -70.93% |
| $73.24M |
| NRXSNeuraxis, INC | $6.00 | — | 11.1x | — | -139.76% | $75.35M |
| RNXTRenovoRx, Inc. | $1.67 | — | 8.4x | — | -125.23% | $75.37M |